Here, we performed this meta-analysis to test overall survival (OS) and disease-free survival (DFS) as outcomes in human CRC with known FoxP3+ Tregs density according to the compartment within tumor they invade. This evidence concerns the gene FOXP3 and colorectal carcinoma.